BioInsights - Downstream Bioprocessing
Downstream Bioprocessing

Vectors

Downstream Bioprocessing

Downstream Bioprocessing
Development of a scalable adeno-associated virus purification process for gene therapy

Development of a scalable adeno-associated virus purification process for gene therapy

Åsa Hagner McWhirter
25 November 2021
FastFacts
COVID-19 vaccine approvals: key lessons for mRNA therapeutics

COVID-19 vaccine approvals: key lessons for mRNA therapeutics

V PhD, J Barberio, S Zobbi et al.
6 December 2021
Poster
Titration for research grade rAAV: understanding challenges and minimum requirements

Titration for research grade rAAV: understanding challenges and minimum requirements

Javier F Alcudia
6 December 2021
Viewpoint
Current trends in AAV downstream bioprocessing and future considerations

Current trends in AAV downstream bioprocessing and future considerations

Michael Mercaldi
6 December 2021
Interview
The route to downstream process and analytical innovation for efficient AAV vector manufacture

The route to downstream process and analytical innovation for efficient AAV vector manufacture

Matthew Roach
6 December 2021
Interview
Enrichment of full rAAV capsids in a scalable, reproducible viral vector manufacturing platform

Enrichment of full rAAV capsids in a scalable, reproducible viral vector manufacturing platform

A Hejmowski, M Olson, A MacIntyre et al.
13 December 2021
Innovator Insight
Stepping foot into a successful partnership to support your viral vector therapy through commercialization

Stepping foot into a successful partnership to support your viral vector therapy through commercialization

Minh Hong, Marc Gaal
12 January 2022
Interview
Purification challenges & considerations with RNA & extracellular vesicles

Purification challenges & considerations with RNA & extracellular vesicles

Zoe Arnott
22 November 2022
Interview

Other editions


<< Back to Vectors channel